Godavari Drugs Ltd (GDRU)

Currency in INR
88.51
-0.04(-0.05%)
Closed·

GDRU Financial Summary

Key Ratios

P/E Ratio15.41
Price/Book1.55
Debt / Equity142.18%
Return on Equity10.64%
Dividend Yield0.00%
EBITDA128.05M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
31/03
2017
31/03
2018
31/03
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
2025
31/03
* In Millions of INR (except for per share items)

Earnings

Latest Release
May 29, 2025
EPS / Forecast
1.19 / --
Revenue / Forecast
256.08M / --
EPS Revisions
Last 90 days

FAQ

What were Godavari Drugs's earnings for the latest quarter?

The Godavari Drugs EPS (TTM) is 5.82. Godavari Drugs reported sales of 255.03, net income of 8.93, and EPS of 1.19 for the latest quarter.

What was Godavari Drugs's net income for the latest quarter?

Godavari Drugs's net income for the latest quarter was 8.93.

How did Godavari Drugs's performance compare year-over-year in the latest quarter?

The company's revenue moved from 296.50 in the previous quarter to 255.03 in the latest quarter, and net income moved from 7.67 to 8.93 compared to the previous quarter.

What is Godavari Drugs's net profit margin on a TTM basis?

Godavari Drugs's trailing twelve months (TTM) net profit margin is 3.83%.

How does Godavari Drugs's debt to equity ratio compare to industry standards?

Godavari Drugs's total debt-to-equity ratio is 142.18%.

What is Godavari Drugs's return on investment on a TTM basis?

Godavari Drugs's trailing twelve months (TTM) return on investment (ROI) is 10.64%.

What were Godavari Drugs's total assets and liabilities in the latest quarter?

As of the latest quarter, Godavari Drugs reported total assets of 1,430.76 million and total liabilities of 730.90 million.

How has Godavari Drugs's total revenue grown this year?

Godavari Drugs's total revenue was 296.50 in the previous quarter and 255.03 in the latest quarter.

What is Godavari Drugs's gross margin on a TTM basis?

Godavari Drugs's trailing twelve months (TTM) gross margin is 28.58%.

What was Godavari Drugs's revenue per share for the latest quarter?

Godavari Drugs's revenue per share for the latest quarter was 294.34.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.